![euan-rellie](https://www.bdapartners.com/wp-content/uploads/2022/06/Euan-Rellie.jpg)
Euan Rellie
Managing Partner, Head of Consumer & Retail
ニューヨーク
Euan Rellie is Co-Founder and Managing Partner of BDA, based in New York. He is also President of BDA Advisors Inc, the firm’s SEC/FINRA registered broker-dealer.
Since founding BDA in 1996, he has lived in New York, London and Singapore. He has worked in China, Hong Kong, India, Japan, Korea, Singapore, Vietnam, and across the Middle East. 1990-1996, he worked for Schroders, the UK investment bank now part of Citigroup, in New York, London and Singapore. He was Head of SE Asia Execution for Schroders Asia-Pacific Regional Advisory Group. His clients have included Ardian, Bain Capital, CITIC Capital, Dainippon Ink & Chemical, DuPont, Ecolab, Flex, Hanjin, Happy Socks, ICICI, Intel, Investcorp, Kraft Foods, Lavazza, Life Technologies, Lubrizol, Materion, Nalco, On Semi, One Equity Partners, OpenGate Capital, Pfizer, Philip Morris, Platinum Equity, Sara Lee, Shimano, Sigma-Aldrich, Tenneco, Terex, ThomsonReuters, Wockhardt and Yucaipa.
He is the recipient of the 2023 M&A Advisor Leadership Award, was named Dealmaker of the Year in 2016 and 2012 (by The M&A Advisor), 2014 North American Investment Banker of the Year, and one of the Top 50 Global M&A Dealmakers (by The Global M&A Network). He was educated at Eton and Trinity College, Cambridge.
Recent transactions
a portfolio company of
has been acquired by
2024
received investment from
2023
raised growth capital from
Beall Investment Partners and
2023
acquired
2023
a portfolio company of
has been sold to
2023
divested India business and formed partnership with
backed by
2022
divested Niigata fab to
Sangyo Sosei and Fukuoka Capital
2022
acquired by
a portfolio company of
2022
divested
to
2022
has been acquired by
2022
raised US$50m in Series B capital and formed a strategic partnership with
2022
has been acquired by
2022
has been acquired by
2021
divested China phenolic resins plant to
2021
has been acquired by
and
2020
divested Escientia Life Sciences to Deccan Fine Chemicals
2020
a portfolio company of
has been acquired by
2020
divested to
a portfolio company of
2020
acquired Rich Graviss
2020
a portfolio business of
divested assets to
2019